Brand unveils four-month awareness campaign featuring Len Dawson, Ken
Griffey Sr., Jim Colbert, Joe Cortez and Rod Woodson to support partnership
with ZERO - The Project to End Prostate Cancer
DALLAS, June 15 /PRNewswire-FirstCall/ -- With prostate cancer affecting
a staggering one in six men and 192,000 men expected to be diagnosed this year
in the United States alone, Kimberly-Clark Corporation (NYSE: KMB) and the
Depend brand today announced a strategic partnership with ZERO - The Project
to End Prostate Cancer. From now through 2010, proceeds from the purchase of
each package of Depend Underwear for Men and Depend Guards for Men will
contribute to a final donation of $250,000 to ZERO(*). The contribution will
help to fund education for patients, free screenings for those at risk and
research to discover a cure.
Coinciding with Men's Health Awareness Week and Father's Day, K-C has
also introduced "The Depend Campaign to End Prostate Cancer," a four-month
prostate health awareness effort which begins today and will culminate in
September during Prostate Cancer Awareness Month. The campaign will aim to
educate men and their families about the risks associated with prostate cancer
and the benefits of early detection in an overall effort to enhance awareness
and bring an end to the disease.
As part of the program, the Depend brand has aligned with a team of
sports legends who each have a unique experience with prostate cancer.
Survivors of the disease, including golf's Jim Colbert, former baseball star
and ZERO board member Ken Griffey, Sr., Pro Football Hall of Famer Len Dawson
and World Boxing Hall of Fame referee Joe Cortez, will join Pro Football Hall
of Fame Class of 2009 inductee Rod Woodson, who at age 44 has pledged to get
screened for the disease for the first time, as campaign ambassadors. All
five men will share their personal stories, interact with consumers online at
Depend.com and participate in various marketing communications activities
which will encourage men to be proactive about their prostate health.
"More than 3.8 million men across the United States are currently
managing some form of incontinence, and the vast majority became afflicted as
a result of a prostate-related issue," said Andrew Meurer, Vice President of
Kimberly-Clark North American Feminine and Adult Care. "The Depend brand has
been for 25 years, and will continue to be, an important resource for men
recovering from prostate health issues. We're proud to team with ZERO and
this group of sports legends to educate men on treatment and prevention
options, but more importantly work to eliminate this condition outright."
Prostate cancer is the second-leading cause of male cancer-related deaths
in the U.S., with an estimated 27,360 fatalities in 2008. It is also the
single most diagnosed non-skin cancer among African-Americans and Hispanics.
However, while prostate cancer is among the most prevalent forms of cancer,
since 2005, nearly 100 percent of men diagnosed with the disease in its early
stages are still alive five years later.
"As an African-American male and someone with a long history of prostate
cancer in my family, I knew my likelihood of contracting the disease was
significant," Griffey, Sr. said. "Luckily, I was educated about the risks and
visited my doctor every year. So when I was ultimately diagnosed with the
disease in 2006, we were fortunate enough to catch it in its early stages, and
it saved my life. That's why I'm happy to team with Depend and ZERO to share
my story with other men."
Early detection remains a critical step to surviving prostate cancer, and
several factors, including proper diet and exercise, can decrease a man's
probability of becoming afflicted.
"I know men can be apprehensive about talking to their doctor about their
prostate health for obvious reasons," said Dawson. "My hope is that people
will hear my story, and it serves as a catalyst for men to start having those
conversations because when it's caught early, prostate cancer is not only
treatable, but beatable. I'm living proof."
Men and their families are encouraged to visit the campaign's online
presence on Depend.com and browse through the Resource Library - a
comprehensive database of articles, essays and tools to help them ask the
right questions and make smart decisions about their prostate health. The
site will be updated throughout the campaign with valuable statistics and an
array of other campaign content including video testimonials from all five of
the campaign's ambassadors.
"Our hope for future generations is that prostate cancer becomes a thing
of the past," said Skip Lockwood, Chief Executive Officer of ZERO - The
Project to End Prostate Cancer. "We commend Kimberly-Clark and the Depend
brand for their commitment to helping us eradicate this disease."
Depend products including Guards for Men and the new Depend Underwear for
Men continue to serve as valued resources for those recovering from prostate
health issues, helping them maintain a normal and active lifestyle.
K-C is the clear leader in the approximately $1.2 billion adult
incontinence category in North America. The company's Depend and Poise brands
hold a combined market share in excess of 50 percent. For more information
about Depend products or "The Depend Campaign to End Prostate Cancer," visit
Kimberly-Clark and its well-known global brands are an indispensable part
of life for people in more than 150 countries. Every day, 1.3 billion people -
nearly a quarter of the world's population - trust K-C brands and the
solutions they provide to enhance their health, hygiene and well-being. With
brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend,
Kimberly-Clark holds No. 1 or No. 2 share positions in more than 80 countries.
To keep up with the latest K-C news and to learn more about the company's
136-year history of innovation, visit www.kimberly-clark.com.
About ZERO - The Project to End Prostate Cancer (ZeroCancer.org)
Zero prostate cancer deaths. Zero prostate cancer cases and for those
with prostate cancer, it means a zero PSA. Our name conveys what we stand for
- zero tolerance for prostate cancer.
At ZERO, we commit ourselves not only to reduce prostate cancer or
alleviate the pain from the disease but to end it. We see a future where all
men who have been diagnosed with prostate cancer will be cured or manage their
illness with good quality of life, with the support they need to minimize
physical and emotional suffering and to cope effectively throughout their
For further information:
For further information: Media, Dave Dickson, +1-972-281-1481,
email@example.com, or Investors, Mike Masseth, +1-972-271-1478,
firstname.lastname@example.org, both of Kimberly-Clark Web Site: